Free shipping on all orders over $ 500

STK321130

Cat. No. M10181
STK321130 Structure
Synonym:

FLT3-IN-2

Size Price Availability Quantity
10mg USD 148  USD148 In stock
25mg USD 250  USD250 In stock
50mg USD 450  USD450 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

STK321130, also known as FLT3-IN-2, is potent FLT3 inhibitor with IC50 of <1 μM.

Chemical Information
Molecular Weight 416.83
Formula C21H16ClF3N4
CAS Number 923562-23-6
Solubility (25°C) DMSO 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Related FLT3 Products
FLT3-IN-19

FLT3-IN-19 is a potent and selective FLT3 inhibitor with IC50 of 0.213 nM.

LT-540-717

LT-540-717 is a potent FLT3 inhibitor (IC50=0.62 nM) with antiproliferative activity.

GTP-14564

GTP-14564 is a tyrosine kinase inhibitor targeting to internal tandem duplication (ITD) and FLT3.

HDAC-IN-63

HDAC-IN-63 is a dual FLT3/HDAC inhibitor (IC50: 0.844 and 30.0 nM for FLT3 and HDAC1 respectively).

FLT3-IN-20

FLT3-IN-20 is a potent FLT3 inhibitor with IC50 values of 1 and 4 nM for FLT3-D835Y and FLT3-ITD, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: STK321130, FLT3-IN-2 supplier, FLT3, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.